Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1988-8-19
|
pubmed:abstractText |
Monkey cells synthesizing SV40 large T antigen were lysed and the extracts immunoprecipitated with either monoclonal anti-T antibody or monoclonal antibody to p110-114, the product of the retinoblastoma susceptibility gene (Rb). T and p110-114 coprecipitated in each case, implying that the proteins are complexed with each other. Substitution and internal deletion mutants of T that contain structural alterations in a ten residue, transformation-controlling domain failed to complex with p110-114. In contrast, T mutants bearing structural changes outside of this domain bound to p110-114. These results are consistent with a model for transformation by SV40 which, at least in part, involves T/p110-114 complex formation and the perturbation of Rb protein and/or T function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0092-8674
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-83
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2839300-Animals,
pubmed-meshheading:2839300-Antibodies, Monoclonal,
pubmed-meshheading:2839300-Antigens, Polyomavirus Transforming,
pubmed-meshheading:2839300-Cell Line,
pubmed-meshheading:2839300-Disease Susceptibility,
pubmed-meshheading:2839300-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:2839300-Eye Neoplasms,
pubmed-meshheading:2839300-Haplorhini,
pubmed-meshheading:2839300-Immunoassay,
pubmed-meshheading:2839300-Mutation,
pubmed-meshheading:2839300-Neoplasm Proteins,
pubmed-meshheading:2839300-Phosphoproteins,
pubmed-meshheading:2839300-Retinoblastoma,
pubmed-meshheading:2839300-Simian virus 40,
pubmed-meshheading:2839300-Transfection
|
pubmed:year |
1988
|
pubmed:articleTitle |
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.
|
pubmed:affiliation |
Division of Neoplastic Disease Mechanisms, Dana-Farber Cancer Institute, Boston, Massachusetts.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|